XML 66 R27.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock-based Compensation Expense

We recorded stock-based compensation expense for the years ended December 31, 2024 and 2023 as follows:

 

   2024   2023 
   Year Ended
December 31,
 
   2024   2023 
Research and development  $169,414   $363,956 
General and administrative   460,100    2,007,258 
Total  $629,514   $2,371,214 
Warrant [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Warrant Valuation Assumption

We used the Black-Scholes option pricing model to calculate the grant date fair value of the two warrants granted in 2023 with the following assumptions:

 

Average risk-free rate of interest   4.32-4.88 %
Expected term (years)   2.003.00   
Expected stock price volatility   82.85-108.47 %
Dividend yield   0%
Share-Based Payment Arrangement, Option [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Restricted Stock Awards (“RSAs”) Activity

The following table summarizes our stock option activity during the years ended December 31, 2023 and 2024:

 

   Total options Outstanding   Weighted average exercise price   Weighted average remaining contractual life
(in years)
 
Outstanding as of January 1, 2023   8,943   $341.34      
Options granted   -           
Forfeited or expired   (1,951)   257.28      
Outstanding as of December 31, 2023   6,992    364.72    2.1 
Options granted   -           
Forfeited or expired   (4,245)   336.00      
Outstanding and exercisable as of December 31, 2024   2,747   $409.09    3.7 
Restricted Award [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Restricted Stock Awards (“RSAs”) Activity

The following table summarizes our restricted stock award (RSA) activity during the years ended December 31, 2023 and 2024:

 

   Number of
shares
   Weighted-
average
grant-date fair
value per share
 
Unvested as of January 1, 2023   3,095   $94.44 
Granted   10,750    14.59 
Forfeited   (1,250)   133.00 
Cancelled   (2,555)   22.13 
Vested and issued   (8,790)   24.44 
Unvested as of December 31, 2023   1,250    9.26 
Granted   -    - 
Forfeited   -    - 
Cancelled   -    - 
Vested and issued   (1,250)   9.26 
           
Unvested as of December 31, 2024   -   $- 
Restricted Stock Units (RSUs) [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Restricted Stock Units (“RSUs”) Activity

The following table summarizes our restricted stock unit (RSU) activity during the years ended December 31, 2023 and 2024:

 

   Number of
shares
   Weighted-
average
grant-date fair
value per share
 
Outstanding at January 1, 2023   135,741   $73.81 
Granted   116,078    14.18 
Forfeited   (12,296)   21.69 
Cancelled   (16,801)   71.36 
Issued   (17,093)   110.59 
Outstanding at December 31, 2023   222,722    45.82 
Granted   192,026    1.63 
Forfeited   (14,019)   71.68 
Issued   (17,093)   110.59 
           
Outstanding at December 31, 2024   383,636    19.87 
Vested and unissued   (149,013)   43.10 
           
Unvested at December 31, 2024   234,623   $5.11 

Warrant [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Warrants Activity

The following table summarizes our warrant activity during the years ended December 31, 2023 and 2024.

 

   Total warrants outstanding   Weighted average exercise price   Weighted average remaining contractual
life (in years)
 
Outstanding as of January 1, 2023   14,283   $205.01      
Granted   173,007    19.27      
Expired   (6,783)   266.96      
Not exercisable   (7,500)   7.40      
Exercisable   7,500    7.40      
Outstanding and exercisable as of December 31, 2023   173,007    25.41    2.2 
Exercisable   7,500    7.40      
Granted   1,617,777    4.54      
Expired or cancelled   (22,500)   54.62      
Outstanding and exercisable as of December 31, 2024   1,775,784   $5.95    3.8